Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.
Hemmerling, M., Nilsson, S., Edman, K., Eirefelt, S., Russell, W., Hendrickx, R., Johnsson, E., Karrman Mardh, C., Berger, M., Rehwinkel, H., Abrahamsson, A., Dahmen, J., Eriksson, A.R., Gabos, B., Henriksson, K., Hossain, N., Ivanova, S., Jansson, A.H., Jensen, T.J., Jerre, A., Johansson, H., Klingstedt, T., Lepisto, M., Lindsjo, M., Mile, I., Nikitidis, G., Steele, J., Tehler, U., Wissler, L., Hansson, T.(2017) J Med Chem 60: 8591-8605
- PubMed: 28937774 
- DOI: 10.1021/acs.jmedchem.7b01215
- Primary Citation of Related Structures:  
5NFP, 5NFT - PubMed Abstract: 
A class of potent, nonsteroidal, selective indazole ether-based glucocorticoid receptor modulators (SGRMs) was developed for the inhaled treatment of respiratory diseases. Starting from an orally available compound with demonstrated anti-inflammatory activity in rat, a soft-drug strategy was implemented to ensure rapid elimination of drug candidates to minimize systemic GR activation ...